---
title: "MYGN: Q2 revenue declined 11% year-over-year, prompting lower 2026 guidance and operational changes"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/294422667.md"
description: "Q2 2026 revenue fell 11% year-over-year to $190.7 million, driven by lower prenatal volumes and payer reimbursement friction, despite strong hereditary cancer and mental health test growth. Guidance for 2026 revenue and gross margin was lowered, and operational initiatives are underway to address reimbursement and efficiency challenges.Based on DisclaimerThis is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source."
datetime: "2026-07-30T22:12:30.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/294422667.md)
  - [en](https://longbridge.com/en/news/294422667.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/294422667.md)
generator: "portal-rs"
---

# MYGN: Q2 revenue declined 11% year-over-year, prompting lower 2026 guidance and operational changes

Q2 2026 revenue fell 11% year-over-year to $190.7 million, driven by lower prenatal volumes and payer reimbursement friction, despite strong hereditary cancer and mental health test growth. Guidance for 2026 revenue and gross margin was lowered, and operational initiatives are underway to address reimbursement and efficiency challenges.

Based on 

**Disclaimer**

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

### Related Stocks

- [MYGN.US](https://longbridge.com/en/quote/MYGN.US.md)

## Related News & Research

- [Myriad Q2 revenue misses estimates, cuts 2026 revenue outlook](https://longbridge.com/en/news/294411320.md)
- [Upwork (UPWK) Q2 2026 Earnings Call Transcript](https://longbridge.com/en/news/296158870.md)
- [Moderna Just Doubled on a Massive Cancer Breakthrough. Here’s Why MRNA Stock Isn’t a Buy Yet.](https://longbridge.com/en/news/296643850.md)
- [iSpecimen ships hundreds of cancer blood specimens for international research order within three weeks](https://longbridge.com/en/news/296531044.md)
- [Granite-Integral co-leads $34 million Series D financing in Craif](https://longbridge.com/en/news/296226716.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**